Paying users area
Try for free
AbbVie Inc. pages available for free this week:
- Income Statement
- Balance Sheet: Liabilities and Stockholders’ Equity
- Common-Size Income Statement
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Long-term (Investment) Activity Ratios
- Enterprise Value to EBITDA (EV/EBITDA)
- Selected Financial Data since 2012
- Return on Assets (ROA) since 2012
- Current Ratio since 2012
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get 1-month access to AbbVie Inc. for $24.99, or
get full access to the entire website for at least 3 months from $62.19.
This is a one-time payment. There is no automatic renewal.
We accept:
Total Debt (Carrying Amount)
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
Debt item | Description | The company |
---|---|---|
Total debt and finance lease obligations (carrying amount) | Sum of the carrying values as of the balance sheet date of all debt plus capital lease obligations. | AbbVie Inc. total debt decreased from 2021 to 2022 and from 2022 to 2023. |
Total Debt (Fair Value)
Dec 31, 2023 | |
---|---|
Selected Financial Data (US$ in millions) | |
Short-term borrowings | |
Current portion of long-term debt and finance lease obligations, excluding fair value hedges | |
Long-term debt and finance lease obligations, excluding fair value hedges | |
Fair value hedges | |
Total debt and finance lease obligations (fair value) | |
Financial Ratio | |
Debt, fair value to carrying amount ratio |
Based on: 10-K (reporting date: 2023-12-31).
Weighted-average Interest Rate on Debt
Weighted-average effective interest rate on debt and finance lease obligations:
Interest rate | Debt amount1 | Interest rate × Debt amount | Weighted-average interest rate2 |
---|---|---|---|
Total | |||
Based on: 10-K (reporting date: 2023-12-31).
1 US$ in millions
2 Weighted-average interest rate = 100 × ÷ =